ICU Medical's GAAP loss for 3 months of 2022 was $38.068 million, compared to a profit of $23.731 million in the previous year. Revenue increased 70.8% to $543.122 million from $318.046 million a year earlier.

ICU Medical's GAAP net income for 2021 was $103.135 million, up 18.7% from $86.87 million in the previous year. Revenue increased 3.5% to $1.316 billion from $1.271 billion a year earlier.

ICU Medical completed its acquisition of Smiths Medical, which makes medical devices such as syringes, IVs and vascular access catheters. As payment, ICU Medical issued 2.5 million shares worth $500 million and paid $1.85 billion in cash. The agreement also includes a $100 million contingent consideration, subject to stock price performance and other conditi...

ICU Medical's GAAP net income for 9M 2021 amounted to $83.21 million, up 37% from $60.728 million in the previous year. Revenue increased by 2.7% to $975.783 million compared to $950.553 million a year earlier.